ARTH Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 apr 2024 @ 19:58):

Stats
Dagens volum	65.00
Gjennomsnittsvolum	3 344.00
Markedsverdi	5.60M
EPS	$0 ( 2024-01-05 )
Neste inntjeningsdato	( $0 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.840
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-08-31	Abrams Michael S	Buy	20 584	Warrants (right to buy)
2023-08-31	Abrams Michael S	Buy	10 292	Common Stock
2023-08-31	Norchi Terrence W	Buy	13 724	Warrants (right to buy)
2023-08-31	Norchi Terrence W	Buy	6 862	Common Stock
2023-08-31	Hicks Laurence	Buy	20 584	Warrants (right to buy)

INSIDER POWER
100.00
Last 89 transactions
Buy: 27 633 666 \| Sell: 2 335 000

Arch Therapeutics, Inc. Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Arch Therapeutics, Inc. Økonomi

Annual	2023
Omsetning:	$75 724.00
Bruttogevinst:	$-2 439.00 (-3.22 %)
EPS:	$-2.27

FY	2023
Omsetning:	$75 724.00
Bruttogevinst:	$-2 439.00 (-3.22 %)
EPS:	$-2.27

FY	2022
Omsetning:	$15 652.00
Bruttogevinst:	$-35 837.00 (-228.96 %)
EPS:	$-3.56

FY	2021
Omsetning:	$11 565.00
Bruttogevinst:	$-14 717.00 (-127.25 %)
EPS:	$-0.0300

Financial Reports:

No articles found.

Arch Therapeutics, Inc.

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.